Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when RZLT files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRezolute reports Q3 FY2026 financial results for quarter ended March 31, 2026
Filed May 12, 2026 · Period ending May 12, 2026 · ~1 min read
Key Changes
-
medium
Rezolute issued a press release announcing financial results for the third quarter of fiscal 2026, which ended March 31, 2026. Specific financial metrics are contained in the attached press release exhibit.
Item 2.02 verify on EDGAR → -
low
The 8-K filing itself contains only the announcement of the press release; detailed financial data, operational updates, and management commentary would be in the press release exhibit (99.1).
Item 9.01 verify on EDGAR →
Summary
Rezolute filed an 8-K to announce its third quarter fiscal 2026 financial results for the period ended March 31, 2026. This is a routine quarterly earnings disclosure required by SEC rules. The filing itself is procedural, with the substantive financial information contained in the attached press release exhibit.
Retail investors should review the full press release (Exhibit 99.1) for actual revenue, expenses, cash position, and any operational updates on the company's drug development programs. As a clinical-stage biopharmaceutical company, Rezolute's quarterly results typically focus on cash runway, clinical trial progress, and research spending rather than product revenue.
Watch for management's guidance on cash reserves and funding needs, as well as any updates on clinical trial timelines for the company's pipeline candidates. These details would be in the press release or any accompanying investor call.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 12, 2026, Rezolute, Inc. issued a press release announcing its financial results for the third quarter ended March 31, 2026.
Rezolute disclosed its financial results for the third quarter of fiscal year 2026, which ended March 31, 2026. The actual financial details are contained in the attached press release (Exhibit 99.1), which is not included in this 8-K body text.
Event · Item 9.01 — Financial Statements and Exhibits
Rezolute filed an 8-K attaching a press release dated May 12, 2026; no material business event disclosed in the filing body.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Exhibit No. | Description | 99.1 | Press Release, dated May 12, 2026
The 8-K references an attached press release dated May 12, 2026. The filing body itself contains no substantive disclosure; the material content would be in the press release exhibit, which is not included in this filing text.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify